Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy.
Talarico C, D'Antona L, Scumaci D, Barone A, Gigliotti F, Fiumara CV, Dattilo V, Gallo E, Visca P, Ortuso F, Abbruzzese C, Botta L, Schenone S, Cuda G, Alcaro S, Bianco C, Lavia P, Paggi MG, Perrotti N, Amato R.
Talarico C, et al. Among authors: barone a.
Oncotarget. 2015 Nov 10;6(35):37511-25. doi: 10.18632/oncotarget.5527.
Oncotarget. 2015.
PMID: 26462020
Free PMC article.